BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11884340)

  • 1. Management of Helicobacter pylori infection. Treatment of ulcers can be improved and over-reliance on proton pump inhibitors reduced.
    Beales IL; Parsons HK; Sanders DS; Carter MJ; Lobo AJ; Watts T
    BMJ; 2002 Mar; 324(7337):614. PubMed ID: 11884340
    [No Abstract]   [Full Text] [Related]  

  • 2. [Healing peptic ulcer disease with therapy of Helicobacter pylori infection--an overview].
    Leodolter A; Peitz U; Malfertheiner P
    Wien Med Wochenschr; 2001; 151(13-14):300-8. PubMed ID: 11582994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current indications for acid suppressants in Helicobacter pylori -negative ulcer disease.
    Howden CW; Leontiadis GI
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):401-12. PubMed ID: 11403535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gastroduodenal ulcer disease: therapeutic possibilities].
    Inauen W
    Praxis (Bern 1994); 1995 May; 84(20):585-9. PubMed ID: 7761731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [History of the treatment of Helicobacter pylori and clinical efficacy].
    Yamamoto I; Fukuda Y; Shimoyama T
    Nihon Rinsho; 1999 Jan; 57(1):32-42. PubMed ID: 10036933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of clarithromycin in eradicating Helicobacter pylori.
    Satoh K; Kimura K; Takimoto T; Kihira K; Taniguchi Y; Saifuku K
    J Gastroenterol; 1996 Nov; 31 Suppl 9():53-5. PubMed ID: 8959520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Methods for increasing the efficacy and safety of Helicobacter pylori eradication regimens].
    Zakharova NV
    Eksp Klin Gastroenterol; 2006; (4):59-66. PubMed ID: 17269426
    [No Abstract]   [Full Text] [Related]  

  • 8. Helicobacter pylori eradication in peptic dyspepsia.
    Lule GN
    East Afr Med J; 2005 Dec; 82(12):601-2. PubMed ID: 16619702
    [No Abstract]   [Full Text] [Related]  

  • 9. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
    Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
    Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Proton pump inhibitors as the basis of anti-helicobacter therapeutic schemes].
    Isakov VA
    Eksp Klin Gastroenterol; 2004; (3):40-4. PubMed ID: 15560400
    [No Abstract]   [Full Text] [Related]  

  • 11. Peptic ulcer disease: defining the treatment strategies in the era of Helicobacter pylori.
    Hunt RH
    Am J Gastroenterol; 1997 Apr; 92(4 Suppl):36S-40S; discussion 40S-43S. PubMed ID: 9127625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Is the successful eradication of Helicobacter pylori sufficient for the healing of peptic ulcer?].
    Pregun I; Herszényi L; Juhász M; Miheller P; Tulassay Z
    Orv Hetil; 2006 Mar; 147(10):435-9. PubMed ID: 16573172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Leaving Helicobacter pylori no chance. Triple therapy should consider resistance status].
    MMW Fortschr Med; 2005 May; 147(20):52. PubMed ID: 15957863
    [No Abstract]   [Full Text] [Related]  

  • 14. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
    Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H
    Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New concepts concerning management of Helicobacter pylori infection: 2 years after the Maastricht Consensus Report.
    Gasbarrini G; Malfertheiner P; Deltenre M; Mégraud F; O'Morain C; Pajares-García J; Quina M; Bianchi Porro G; Gasbarrini A; Franceschi F; Armuzzi A; Cammarota G; Anti M; Pretolani S
    Ital J Gastroenterol Hepatol; 1998 Oct; 30 Suppl 3():S244-7. PubMed ID: 10077746
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of Helicobacter pylori eradication therapy on the healing process of peptic ulcers].
    Imaizumi H; Koizumi W; Nakai H; Tanabe S; Ohida M; Saigenji K
    Nihon Rinsho; 1999 Jan; 57(1):167-72. PubMed ID: 10036957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Helicobacter pylori eradication therapy in cirrhotic patients with peptic ulcer disease.
    Mitrică D; Pleşa A; Constantinescu R; Drug V; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):367-74. PubMed ID: 21870725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Getting the right cure for ulcers.
    Johns Hopkins Med Lett Health After 50; 1998 Mar; 10(1):1-2. PubMed ID: 9600052
    [No Abstract]   [Full Text] [Related]  

  • 19. [The attitude of primary health care physicians in the metropolitan area of Barcelona about the diagnosis and treatment of Helicobacter pylori infection in gastroduodenal diseases].
    Martínez-Sánchez G; Saperas E; Benavent J; Mearin F; Piñol JL; Barenys M; Mascort JJ; Forné M; Bordas JM; Azagra R; Piqué JM
    Gastroenterol Hepatol; 1998 Dec; 21(10):473-8. PubMed ID: 9927791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in proton pump inhibitors and management of acid-peptic disorders.
    Jain KS; Shah AK; Bariwal J; Shelke SM; Kale AP; Jagtap JR; Bhosale AV
    Bioorg Med Chem; 2007 Feb; 15(3):1181-205. PubMed ID: 17150362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.